Front Range Urgent Care, INC.
Front Range Urgent Care, INC. was paid $4.70M by Medicaid between Jan 2018 and Apr 2024, across 41 billing codes. Its largest line is 87502, Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets — 17% of everything it billed.
PUEBLO, CO 81008
Next to other Family Medicine Physician providers in Colorado
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,059 | $523K | |
| 2019 | 16,892 | $888K | |
| 2020 | 27,020 | $681K | |
| 2021 | 27,761 | $1.01M | |
| 2022 | 21,407 | $802K | |
| 2023 | 10,705 | $664K | |
| 2024incomplete | 1,915 | $134K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 17% | 11,873 | 6,064 | $811K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 10,266 | 8,070 | $763K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 14% | 6,174 | 4,659 | $636K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 11% | 6,855 | 5,564 | $505K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 6.6% | 13,785 | 8,549 | $308K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.8% | 4,884 | 4,197 | $274K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 5.3% | 2,594 | 2,008 | $250K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.0% | 6,405 | 5,361 | $234K |
| 87631 | 4.6% | 1,582 | 1,540 | $216K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.5% | 5,478 | 4,327 | $211K |
| 96127 | 3.0% | 10,400 | 8,612 | $140K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 1.4% | 7,633 | 6,272 | $67K |
29 more codes
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 1.4% | 2,548 | $65K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.1% | 410 | $54K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.1% | 1,421 | $52K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 748 | $37K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,781 | $17K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 444 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 567 | $8K |
| 87634 | <1% | 112 | $6K | |
| 81002 | <1% | 2,769 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 382 | $5K |
| 99000 | <1% | 8,537 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 532 | $4K |
| 86308 | <1% | 358 | $2K | |
| 99050 | <1% | 244 | $1K | |
| 36416 | <1% | 386 | $991.29 | |
| 87807 | <1% | 79 | $883.88 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 67 | $849.20 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 111 | $603.26 |
| 36415 | Collection of venous blood by venipuncture | <1% | 103 | $275.66 |
| 90686 | <1% | 43 | $272.25 | |
| 81025 | <1% | 46 | $225.18 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 185 | $104.11 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 933 | $100.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 432 | $34.01 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 494 | $12.48 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $8.17 |
| 94760 | <1% | 20 | $5.08 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 21 | $2.98 |
| 99051 | 0% | 44 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Front Range Urgent Care, INC. | Colorado Springs, CO | $2.96M |
| Front Range Urgent Care, INC. | Fountain, CO | $2.69M |
| Comfort Care Family Practice, INC. | Colorado Springs, CO | $2.03M |
| Comfort Care Family Practice, INC. | Fountain, CO | $1.34M |
| Comfort Care Family Practice, INC. | Pueblo, CO | $732K |
| Front Range Urgent Care, INC. | Colorado Springs, CO | $376K |
| Comfort Care Family Practice, INC. | Colorado Springs, CO | $76K |
| Front Range Urgent Care, INC. | Colorado Springs, CO | $28K |
| Front Range Urgent Care, INC. | Colorado Springs, CO | $15K |
| Comfort Care Family Practice, INC. | Colorado Springs, CO | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.